Literature DB >> 18404621

Adverse drug reactions reporting by physicians in Ibadan, Nigeria.

Enwere O Okezie1, Fawole Olufunmilayo.   

Abstract

OBJECTIVE: To assess knowledge, extent of reporting and factors influencing reports of adverse drug reactions (ADRs) by resident doctors. STUDY DESIGN AND
SETTING: Study site was the University College Hospital (UCH), Ibadan, an 850-bed tertiary care hospital in western Nigeria. It was a cross-sectional survey. Data were collected with a 46-item self-administered questionnaire from 192 clinical physicians.
RESULTS: Older aged doctors, senior cadre and doctors in medical faculty were 1.5 times likely to be aware of ADR reporting guidelines. General knowledge on ADR was good while 58.3% of residents knew the burden of ADRs. Most (89.5%) had observed at least one ADR but only 32% had ever reported it. Residents in medical faculty were twice more likely to report ADRs than the surgeons [OR 2.1; 95%CI 1.1, 4.1]. The commonest factors that militate against ADR reporting were lack of knowledge that reporting forms were available (70.9%) and ignorance of reporting procedure (69%).
CONCLUSION: Despite high observation and good knowledge of ADR among doctors, the rate of reporting was low. There is need for publicity of activities of the pharmacovigilance unit of the hospital.

Mesh:

Year:  2008        PMID: 18404621     DOI: 10.1002/pds.1597

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  23 in total

1.  Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from klang valley in malaysia.

Authors:  Renu Agarwal; Aqil Mohammad Daher; Nafeeza Mohd Ismail
Journal:  Malays J Med Sci       Date:  2013-03

2.  Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana.

Authors:  G T Sabblah; P Akweongo; D Darko; A N O Dodoo; A M Sulley
Journal:  Ghana Med J       Date:  2014-12

3.  Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers.

Authors:  Amira S A Said; Nadia Hussain
Journal:  Hosp Pharm       Date:  2017-05-01

4.  Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria.

Authors:  Theophilus A Adegbuyi; Joseph O Fadare; Ebisola J Araromi; Abayomi O Sijuade; Iyanu Bankole; Ilesanmi K Fasuba; Rachel A Alabi
Journal:  Hosp Pharm       Date:  2020-09-18

5.  Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.

Authors:  Krisha Danekhu; Sunil Shrestha; Sushant Aryal; P Ravi Shankar
Journal:  Hosp Pharm       Date:  2019-11-05

6.  Comparative study on drug safety surveillance between medical students of Malaysia and Nigeria.

Authors:  Abdullahi Rabiu Abubakar; Salwani Ismail; Nor Iza A Rahman; Mainul Haque
Journal:  Ther Clin Risk Manag       Date:  2015-06-30       Impact factor: 2.423

7.  Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Jacob O Awobusuyi
Journal:  BMC Clin Pharmacol       Date:  2009-08-11

8.  Interns' knowledge of clinical pharmacology and therapeutics after undergraduate and on-going internship training in Nigeria: a pilot study.

Authors:  Kazeem A Oshikoya; Idowu O Senbanjo; Olufemi O Amole
Journal:  BMC Med Educ       Date:  2009-07-28       Impact factor: 2.463

9.  Spontaneous reporting of adverse drug reactions through electronic submission from regional society healthcare professionals in Korea.

Authors:  Jae-Hyun Lee; Kyung Hee Park; Hyun Joo Moon; Yong Won Lee; Jung-Won Park; Chein-Soo Hong
Journal:  Yonsei Med J       Date:  2012-09       Impact factor: 2.759

10.  Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal.

Authors:  Subish Palaian; Mohamed I Ibrahim; Pranaya Mishra
Journal:  Pharm Pract (Granada)       Date:  2011-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.